The earnings call highlights significant progress in regulatory approvals, commercial readiness, and strategic cash management, alongside industry recognition. However, challenges remain with pending FDA clearance and cash constraints.

Company Guidance

During the HeartBeam Second Quarter 2025 Financial Results Conference Call, key metrics and guidance were shared by Rob Eno, CEO, and Tim Cruickshank, CFO. The company highlighted its progress towards commercial readiness, including FDA 510(k) clearance for its portable ECG system, expected by the end of 2025. This clearance is pivotal for the commercial launch. HeartBeam's focus is on reducing cash burn, achieving a 23% decrease in operating activities, and maintaining a cash balance of $5.1 million. They anticipate a $250 million to $500 million annual recurring revenue from a target segment of 1.5 million patients. Additionally, collaborations with AccurKardia for arrhythmia assessment and strategic partnerships are underway to enhance their ecosystem. The initial commercialization will target concierge and preventive cardiology practices in Florida and Southern California.

FDA 510(k) Clearance Achieved

HeartBeam received foundational FDA 510(k) clearance for their portable cable-free ECG system, a major milestone validating their approach.

Commercial Readiness and Launch Plans

HeartBeam is preparing for a pilot commercial launch in Florida and Southern California, targeting concierge practices with a potential market of $250 million to $500 million in annual recurring revenue.

Capital Efficiency and Cash Management

HeartBeam reduced net cash used in operating activities by 23% from the previous quarter, with strategic cost reductions to extend runway.

Industry Recognition

HeartBeam was awarded the Innovation in Remote Cardiac Diagnostics honor and is a finalist for the 2025 Octane High-Tech Awards.

HeartBeam (BEAT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

BEAT Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 06, 2025	2025 (Q3)	-0.12 / -	-0.19	―	―	―
Aug 13, 2025	2025 (Q2)	-0.16 / -0.15	-0.19	21.05% (+0.04)
May 13, 2025	2025 (Q1)	-0.15 / -0.18	-0.17	-5.88% (>-0.01)
Mar 13, 2025	2024 (Q4)	-0.19 / -0.18	0.07	-357.14% (-0.25)
Nov 07, 2024	2024 (Q3)	-0.17 / -0.19	-0.13	-46.15% (-0.06)
Aug 14, 2024	2024 (Q2)	-0.17 / -0.19	-0.16	-18.75% (-0.03)
May 09, 2024	2024 (Q1)	-0.15 / -0.17	-0.5	66.00% (+0.33)
Mar 20, 2024	2023 (Q4)	-0.12 / 0.07	-0.45	115.56% (+0.52)
Nov 14, 2023	2023 (Q3)	-0.11 / -0.13	-0.44	70.45% (+0.31)
Aug 10, 2023	2023 (Q2)	-0.23 / -0.16	-0.43	62.79% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

BEAT Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 13, 2025	$1.20	$1.11	-7.50%
May 13, 2025	$1.71	$1.60	-6.43%
Mar 13, 2025	$2.02	$2.05	+1.49%
Nov 07, 2024	$2.33	$2.57	+10.30%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does HeartBeam (BEAT) report earnings?

HeartBeam (BEAT) is schdueled to report earning on Nov 06, 2025, After Close (Confirmed).

What is HeartBeam (BEAT) earnings time?

HeartBeam (BEAT) earnings time is at Nov 06, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is BEAT EPS forecast?

BEAT EPS forecast for the fiscal quarter 2025 (Q3) is -0.12.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing